Cas:82597-74-8 Spirostan-3-ol manufacturer & supplier

Chemical Name:Spirostan-3-ol

CAS.NO:82597-74-8

Synonyms:Smilagenin;Sarsaponin;neo-tigogenin;Spirostan-3-ol;Tigogenin

Molecular Formula:C₂₇H₄₄O₃

Molecular Weight:416.637

HS Code:

Physical and Chemical Properties:

Melting point:18ºC

Boiling point:516.6±20.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.552

PSA:38.69000

Exact Mass:416.329041

LogP:6.21

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Smilagenin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tigogenin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,neo-tigogenin Use and application,Spirostan-3-ol technical grade,usp/ep/jp grade.

Related News: Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei. Spirostan-3-ol manufacturer China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. Spirostan-3-ol supplier Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. Spirostan-3-ol vendor In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining. Spirostan-3-ol factory Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue.